A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The primary objective of the clinical study is to evaluate the efficacy and safety for Mikelan LA eye drops 2% (once per day) of intra-ocular pressure decreased.
Epistemonikos ID: b0080fa7b0dab42e019c13fba99239906b93eee5
First added on: May 05, 2024